0001104659-19-034521.txt : 20190607 0001104659-19-034521.hdr.sgml : 20190607 20190607160123 ACCESSION NUMBER: 0001104659-19-034521 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190605 FILED AS OF DATE: 20190607 DATE AS OF CHANGE: 20190607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KOVEN ANDREW I CENTRAL INDEX KEY: 0001258673 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38150 FILM NUMBER: 19885646 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE, SUITE 1710 STREET 2: C/O ARALEZ PHARMACEUTICALS INC. CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001479419 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270604595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BEAVER STREET STREET 2: SUITE 201 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 781-996-5252 MAIL ADDRESS: STREET 1: 100 BEAVER STREET STREET 2: SUITE 201 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 a4.xml 4 X0306 4 2019-06-05 0 0001479419 Kala Pharmaceuticals, Inc. KALA 0001258673 KOVEN ANDREW I C/O KALA PHARMACEUTICALS, INC. 490 ARSENAL WAY, SUITE 120 WATERTOWN MA 02472 1 0 0 0 Stock Option (right to buy) 5.35 2019-06-05 4 A 0 21000 0 A 2029-06-04 Common Stock 21000 21000 D This option was granted on June 5, 2019 and vests with respect to 1/12th of the shares underlying the option at the end of each successive one-month period thereafter. /s/ Mary Reumuth, Attorney-in-Fact 2019-06-07